Background
Autism spectrum disorder (ASD) is a complex neurodevelopmental condition that can be reliably diagnosed as early as 24 months. Immunological phenomena, including skewed cytokine production, have been observed among children with ASD. Little is known about whether immune dysregulation is present before diagnosis of ASD.
Methods
We utilized neonatal blood spots from 214 children with ASD (141 severe, 73 mild/moderate), 62 typically developing (TD), and 27 developmental delayed controls who participated in CHARGE (Childhood Autism Risks from Genetics and the Environment), a population-based case-control study. Levels of 17 cytokines/chemokines were compared across groups and in relation to developmental/behavioral domains.
Results
Interleukin (IL)-1β and IL-4 were independently associated with ASD vs. TD although these relationships varied by ASD symptom intensity. Elevated IL-4 associated with increased odds of severe ASD (ASDsev) (odds ratio[OR]=1.40, 95% confidence interval[CI] 1.03, 1.91) whereas IL-1β associated with increased odds of mild/moderate ASD (ASDmild) (OR=3.02, 95% CI 1.43, 6.38). Additionally, IL-4 was associated with a higher likelihood of ASDsev vs. ASDmild (OR=1.35, 95% CI 1.04, 1.75). In male ASD cases, IL-4 was negatively associated with non-verbal cognitive ability (β=−3.63, SE=1.33, P=0.04).
Conclusions
This study is part of a growing effort to identify early biological markers for ASD. We demonstrate that peripheral cytokine profiles at birth are associated with ASD later in childhood and that cytokine profiles vary depending on ASD severity. Cytokines have complex roles in neurodevelopment, and dysregulated levels may be indicative of genetic differences and environmental exposures or their interactions that relate to ASD.